🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsRetatrutide & Triple AgonistsTRIUMPH program trial design overview — all Phase 3 arms Page 10

TRIUMPH program trial design overview — all Phase 3 arms

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 324 replies 45,778 viewsPage 10 of 20
steve_okc
Member
489
2,123
Jul 2024
Oklahoma City, OK
Jun 7, 2024 at 8:21 PM#46
EndoResFellow said:
Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

Adding the part of the answer the thread has not reached. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.

34 9NauseaFreeNow, SteveThurs, B12Beth and 31 others
Reply Quote Save Share Report
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Jun 11, 2024 at 9:59 AM#47

OP back with an update, since a thread like this is useless without one.

Reporting back with a partial result, because a partial result is still better than silence. Two of the three things suggested helped; I cannot separate them and I am not going to pretend otherwise.

Last edited: Jun 11, 2024 at 2:59 PM
33 8stefan_berlin, Dr.EM_Chicago, pete_RVA and 30 others
Reply Quote Save Share Report
TomFromTexas
Member
645
2,890
May 2024
Austin, TX
Jun 14, 2024 at 11:35 PM#48

Following on from EndoResFellow — and this may be the naive question:

What would you measure differently if you were starting again?

32 7Dr.KarenChen, Dr.NateNeph, PharmD_Rodriguez and 29 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
paul_denver
Member
723
3,234
May 2024
Denver, CO
Jun 18, 2024 at 1:09 PM#49
TrialTracker_MD said:
Reporting back with a partial result, because a partial result is still better than silence.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The objection nobody has made: this only works if the measurement is doing what we assume it is doing, and that assumption has not been tested here.

Worth separating that from the trial evidence, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

Last edited: Jun 18, 2024 at 7:09 PM
31 6sarah_TO, wendy_avl, jason_paloalto and 28 others
Reply Quote Save Share Report
andrew_nyc
Member
534
2,345
Apr 2024
New York, NY
Jun 22, 2024 at 2:41 AM#50
TrialTracker_MD said:
Reporting back with a partial result, because a partial result is still better than silence.

Agreed, and one caution: a single measurement is not a measurement. Anything that moves day to day needs a trend before it means anything at all.

9 9JessicaM_2024, TomFromTexas, mike.trainer_LA and 6 others
Reply Quote Save Share Report

Similar Threads

TRIUMPH-3 topline results — 24.2% body weight loss at 48 weeks10 replies
Retatrutide mechanism: GLP-1/GIP/glucagon triple agonism explained5 replies
Retatrutide Phase 2 dose-response analysis — optimal dose range10 replies
Glucagon receptor agonism and hepatic lipid oxidation — MASH implications13 replies
Retatrutide vs tirzepatide — dual vs triple agonist comparison22 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register